Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Denes

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Neuroscience|February 8, 2019
Editorial for the Special Issue: Microglia-Neuron interactions in health and disease - novel perspectives for translational researchAmanda Sierra, Adam Denes
IUBMB Life|April 25, 2015
Interleukin-1α and brain inflammationDavid Brough, Adam Denes
Frontiers in Neuroscience|December 19, 2014
Brain-immune interactions in health and diseaseAdam Denes, Jaleel A Miyan
Journal of Neuroimmunology|March 6, 2016
Emerging roles of the acute phase protein pentraxin-3 during central nervous system disordersIvana Rajkovic, Adam Denes, Stuart M Allan, et al.
Frontiers in Immunology|October 2, 2012
NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after InjuryCatherine Diane Savage, Gloria Lopez-Castejon, Adam Denes, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 23, 2011
Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic targetAdam Denes, Emmanuel Pinteaux, Nancy J Rothwell, et al.
Stroke|July 2, 2011
Letter by McColl et al regarding article, "influenza virus infection aggravates stroke outcome"Barry W McColl, Stuart M Allan, Adam Denes, et al.
Molecular and Cellular Neurosciences|October 3, 2012
Systemic immune activation shapes stroke outcomeKatie N Murray, Hannah F Buggey, Adam Denes, et al.
Brain, Behavior, and Immunity|December 13, 2012
Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemiaBeatriz Rodriguez-Grande, Victoria Blackabey, Beatrice Gittens, et al.
Expert Opinion on Investigational Drugs|March 3, 2015
Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic strokeCraig J Smith, Adam Denes, Pippa J Tyrrell, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Neuroscience|February 8, 2019
Editorial for the Special Issue: Microglia-Neuron interactions in health and disease - novel perspectives for translational researchAmanda Sierra, Adam Denes
IUBMB Life|April 25, 2015
Interleukin-1α and brain inflammationDavid Brough, Adam Denes
Frontiers in Neuroscience|December 19, 2014
Brain-immune interactions in health and diseaseAdam Denes, Jaleel A Miyan
Journal of Neuroimmunology|March 6, 2016
Emerging roles of the acute phase protein pentraxin-3 during central nervous system disordersIvana Rajkovic, Adam Denes, Stuart M Allan, et al.
Frontiers in Immunology|October 2, 2012
NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after InjuryCatherine Diane Savage, Gloria Lopez-Castejon, Adam Denes, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 23, 2011
Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic targetAdam Denes, Emmanuel Pinteaux, Nancy J Rothwell, et al.
Stroke|July 2, 2011
Letter by McColl et al regarding article, "influenza virus infection aggravates stroke outcome"Barry W McColl, Stuart M Allan, Adam Denes, et al.
Molecular and Cellular Neurosciences|October 3, 2012
Systemic immune activation shapes stroke outcomeKatie N Murray, Hannah F Buggey, Adam Denes, et al.
Brain, Behavior, and Immunity|December 13, 2012
Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemiaBeatriz Rodriguez-Grande, Victoria Blackabey, Beatrice Gittens, et al.
Expert Opinion on Investigational Drugs|March 3, 2015
Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic strokeCraig J Smith, Adam Denes, Pippa J Tyrrell, et al.
Pageof 5